GTR 117652617
Tenders Are Invited For Amivantamab As Part Of Implementation B.6 Treatment Of Lung Cancer Treatment Of Lung Cancer And Mesotheliomapleura
ICB — International Competitive Bid
Closes Sep 17, 2026
— 5 days left
central europe
Tender Information
GTR Reference
117652617
Tendering Authority
Subscribe to view
Tender No
DZP/216/2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Amivantamab As Part Of Implementation B.6 Treatment Of Lung Cancer Treatment Of Lung Cancer And Mesotheliomapleura
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
central europe
Political Region
European Union
Last Date of Bid Submission
17-09-2026
5 days left
Work Detail
Amivantamab As Part Of Implementation B.6 Treatment Of Lung Cancer Treatment Of Lung Cancer And Pleural Mesothelioma - Subcutaneous Form Of Administration
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
944bb6d0-6218-413c-9473-bf9931f650a1.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.